BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo P, Liu D, Zhang Q, Yang F, Wong YK, Xia F, Zhang J, Chen J, Tian Y, Yang C, Dai L, Shen HM, Wang J. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharm Sin B 2022;12:2300-14. [PMID: 35646542 DOI: 10.1016/j.apsb.2021.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu Y, Zhang C, Guo M, Hu W, Qiu Y, Li M, Xu D, Wu P, Sun J, Shi R, Zhang Z, Jiang K. Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds. Front Pharmacol 2022;13:1042651. [DOI: 10.3389/fphar.2022.1042651] [Reference Citation Analysis]
2 Thapa P, Ding N, Hao Y, Alshahrani A, Jiang H, Wei Q. Essential Roles of Peroxiredoxin IV in Inflammation and Cancer. Molecules 2022;27:6513. [PMID: 36235049 DOI: 10.3390/molecules27196513] [Reference Citation Analysis]
3 Wang T, Zhou Y, Zheng H, Shen T, Wang D, Zhang J. Chemoproteomics identifies Ykt6 as the direct target of schisandrin A for neuroprotection. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.107887] [Reference Citation Analysis]
4 Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, Kong L, Xu Q, Ma H, Sun Y. New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]